TEQCool introduces a groundbreaking approach to brain cooling—targeted, non-invasive, and fast. Unlike traditional whole-body methods, our solution leverages the nasal cavity’s natural heat exchange to deliver precise temperature management directly to the brain to reduce brain metabolism, oxygen demand, and fever at the point of need. Our technology has the potential to minimize systemic risks and enable earlier, safer intervention in neurocritical care. Backed by science and engineered for real-world impact, the TEQCool method sets a new standard in personalized brain protection.
Temperature management is vital in neurocritical care. One of its most critical applications is targeted brain cooling, where lowering brain temperature helps prevent secondary injury and support recovery.
TEQCool’s therapeutic hypothermia solution is dedicated to reduce patient brain temperature through intranasal cooling, where energy is exchanged with the patient via balloon catheters placed in the nasal cavity.
Our innovative brain cooling treatment is intended for use in critically brain-injured patients with persistent, hard-to-treat fever, especially in neuro-intensive care settings where swift, targeted action can be life-saving.